Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 779-784, March 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holtzman, S.
Right arrow Articles by Shellabarger, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holtzman, S.
Right arrow Articles by Shellabarger, C. J.

Influence of Diethylstilbestrol Treatment on Prolactin Cells of Female ACI and Sprague-Dawley Rats1

Seymour Holtzman2, John Patrick Stone and Claire J. Shellabarger

Medical Department, Brookhaven National Laboratory,3 Upton, New York 11973

In a comparative study, female ACI and Sprague-Dawley rats were implanted with pellets containing 5 mg diethylstilbestrol (DES) and 15 mg cholesterol for periods ranging from 2 to 214 days. Strain differences in mammary tumorigenesis, plasma prolactin levels, and gross pituitary responses indicated a desirability for examining the cytology of pituitary glands that were fixed during the course of this study and an immunohistochemical evaluation of their prolactin cell responses. Although plasma prolactin levels were elevated in both strains by 2 days after DES pellet implantation, during the first 10 days of treatment there were no significant increases in pituitary weight in both strains. Pituitary glands from experimental animals of both strains killed on Day 10 exhibited enlarged anti-rat prolactin-binding cells. By Day 28, the pituitary glands of DES-treated ACI rats were significantly enlarged, and a hypertrophic and hyperplastic response of their prolactin cells was detected. From Day 56 to the end of the experiment, gross pituitary tumorigenesis was evident in the ACI but not in the Sprague-Dawley rats. At the microscopic level, adenomatous lesions involving prolactin cell hyperplasia were observed in both strains. Sprague-Dawley and ACI rats exhibited multiple centers of marked vascularization predominated by granular acidophilic cells. These centers were more extensive and larger in the pituitaries of the ACI rats. Two types of immunoreactive prolactin cells were observed in lesioned pituitary glands of both strains: polyhedral, strongly reactive cells which were hypertrophic and more numerous in the ACI rats; and smaller, weakly reactive cells which were numerous in the adenomatous areas of the glands in both strains. It was concluded that the lesions in ACI and Sprague-Dawley females represented different quantitative responses of their prolactin cells to DES treatment.

1 Research performed under United States Department of Energy Contract EY-76-C-02-0016, National Cancer Institute Contract Y01-CP-30213, and USPHS Grant 5-T01-Ca-05243.

2 To whom requests for reprints should be addressed.

3 Operated by Associated Universities, Inc., under contract to the United States Department of Energy.

Received 8/18/78. Accepted 11/28/78.




This article has been cited by other articles:


Home page
GeneticsHome page
T. E. Strecker, T. J. Spady, B. S. Schaffer, K. A. Gould, A. E. Kaufman, F. Shen, M. T. McLaughlin, K. L. Pennington, J. L. Meza, and J. D. Shull
Genetic Bases of Estrogen-Induced Pituitary Tumorigenesis: Identification of Genetic Loci Determining Estrogen-Induced Pituitary Growth in Reciprocal Crosses Between the ACI and Copenhagen Rat Strains
Genetics, April 1, 2005; 169(4): 2189 - 2197.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Pandey, A. Bannout, and D. L. Wendell
The Edpm5 locus prevents the 'angiogenic switch' in an estrogen-induced rat pituitary tumor
Carcinogenesis, October 1, 2004; 25(10): 1829 - 1838.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. T. Hentges and M. J. Low
Ovarian Dependence for Pituitary Tumorigenesis in D2 Dopamine Receptor-Deficient Mice
Endocrinology, December 1, 2002; 143(12): 4536 - 4543.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. M. Fitts, R. M. Klein, and C. A. Powers
Estrogen and Tamoxifen Interplay with T3 in Male Rats: Pharmacologically Distinct Classes of Estrogen Responses Affecting Growth, Bone, and Lipid Metabolism, and Their Relation to Serum GH and IGF-I
Endocrinology, October 1, 2001; 142(10): 4223 - 4235.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. J. Spady, K. L. Pennington, R. D. McComb, and J. D. Shull
Genetic Bases of Estrogen-Induced Pituitary Growth in an Intercross between the ACI and Copenhagen Rat Strains: Dominant Mendelian Inheritance of the ACI Phenotype
Endocrinology, June 1, 1999; 140(6): 2828 - 2835.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
T. J. Spady, D. M. E. Harvell, A. Lemus-Wilson, T. E. Strecker, K. L. Pennington, E. A. Vander Woude, D. F. Birt, R. D. McComb, and J. D. Shull
Modulation of Estrogen Action in the Rat Pituitary and Mammary Glands by Dietary Energy Consumption
J. Nutr., February 1, 1999; 129(2): 587 - 587.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J.A. Clapper, J.L. Snyder, A.J. Roberts, D.L. Hamernik, and G.E. Moss
Estradiol Increases Relative Amounts of Insulin-Like Growth Factor Binding Protein (IGFBP)-3 in Serum and Expression of IGFBP-2 in Anterior Pituitaries of Ewes
Biol Reprod, July 1, 1998; 59(1): 124 - 130.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.